Inhibikase TherapeuticsInc Stock Forecast - Daily Balance Of Power
| IKT Stock | USD 1.99 0.45 29.22% |
Inhibikase Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Inhibikase TherapeuticsInc stock prices and determine the direction of Inhibikase TherapeuticsInc's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Inhibikase TherapeuticsInc's historical fundamentals, such as revenue growth or operating cash flow patterns. Although Inhibikase TherapeuticsInc's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Inhibikase TherapeuticsInc's systematic risk associated with finding meaningful patterns of Inhibikase TherapeuticsInc fundamentals over time.
Check out Historical Fundamental Analysis of Inhibikase TherapeuticsInc to cross-verify your projections. Inhibikase |
Most investors in Inhibikase TherapeuticsInc cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Inhibikase TherapeuticsInc's time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Inhibikase TherapeuticsInc's price structures and extracts relationships that further increase the generated results' accuracy.
Balance of Power indicator (or BOP) measures the strength of Inhibikase TherapeuticsInc market sensitivity to bulls and bears. It estimates the ability of Inhibikase TherapeuticsInc buyers and sellers to push price to an extreme high or extreme low level. As a result, by monitoring Inhibikase TherapeuticsInc Balance of Power indicator one can determine a trend of the price direction.| Previous Daily Balance Of Power | Daily Balance Of Power | Trend |
| 0.6667 | 0.6716 |
| Check Inhibikase TherapeuticsInc Volatility | Backtest Inhibikase TherapeuticsInc | Information Ratio |
Inhibikase TherapeuticsInc Trading Date Momentum
| On May 15 2024 Inhibikase TherapeuticsInc was traded for 1.99 at the closing time. Highest Inhibikase TherapeuticsInc's price during the trading hours was 2.22 and the lowest price during the day was 1.55 . The net volume was 567.1 K. The overall trading history on the 15th of May 2024 did not cause price change. The trading delta at closing time to current price is 20.60% . |
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
| Compare Inhibikase TherapeuticsInc to competition |
Other Forecasting Options for Inhibikase TherapeuticsInc
For every potential investor in Inhibikase, whether a beginner or expert, Inhibikase TherapeuticsInc's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Inhibikase Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Inhibikase. Basic forecasting techniques help filter out the noise by identifying Inhibikase TherapeuticsInc's price trends.Inhibikase TherapeuticsInc Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Inhibikase TherapeuticsInc stock to make a market-neutral strategy. Peer analysis of Inhibikase TherapeuticsInc could also be used in its relative valuation, which is a method of valuing Inhibikase TherapeuticsInc by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Inhibikase TherapeuticsInc Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Inhibikase TherapeuticsInc's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Inhibikase TherapeuticsInc's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Inhibikase TherapeuticsInc Market Strength Events
Market strength indicators help investors to evaluate how Inhibikase TherapeuticsInc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Inhibikase TherapeuticsInc shares will generate the highest return on investment. By undertsting and applying Inhibikase TherapeuticsInc stock market strength indicators, traders can identify Inhibikase TherapeuticsInc entry and exit signals to maximize returns.
| Accumulation Distribution | 171140.0 | |||
| Daily Balance Of Power | 0.6716 | |||
| Rate Of Daily Change | 1.29 | |||
| Day Median Price | 1.89 | |||
| Day Typical Price | 1.92 | |||
| Price Action Indicator | 0.33 | |||
| Period Momentum Indicator | 0.45 |
Inhibikase TherapeuticsInc Risk Indicators
The analysis of Inhibikase TherapeuticsInc's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Inhibikase TherapeuticsInc's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting inhibikase stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.11 | |||
| Standard Deviation | 6.6 | |||
| Variance | 43.6 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of Inhibikase TherapeuticsInc to cross-verify your projections. For more information on how to buy Inhibikase Stock please use our How to Invest in Inhibikase TherapeuticsInc guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Complementary Tools for Inhibikase Stock analysis
When running Inhibikase TherapeuticsInc's price analysis, check to measure Inhibikase TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibikase TherapeuticsInc is operating at the current time. Most of Inhibikase TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Inhibikase TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibikase TherapeuticsInc's price. Additionally, you may evaluate how the addition of Inhibikase TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |
Is Inhibikase TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inhibikase TherapeuticsInc. If investors know Inhibikase will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inhibikase TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.57) | Revenue Per Share 0.049 | Quarterly Revenue Growth (1.00) | Return On Assets (0.64) | Return On Equity (1.19) |
The market value of Inhibikase TherapeuticsInc is measured differently than its book value, which is the value of Inhibikase that is recorded on the company's balance sheet. Investors also form their own opinion of Inhibikase TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Inhibikase TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inhibikase TherapeuticsInc's market value can be influenced by many factors that don't directly affect Inhibikase TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inhibikase TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inhibikase TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inhibikase TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.